N

Noile-Immune Biotech Inc
TSE:4893

Watchlist Manager
Noile-Immune Biotech Inc
TSE:4893
Watchlist
Price: 146 JPY 5.04% Market Closed
Market Cap: 6.3B JPY

Wall Street
Price Targets

Price Targets Summary
Noile-Immune Biotech Inc

There are no price targets for Noile-Immune Biotech Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Noile-Immune Biotech Inc Competitors:
Price Targets
ARMP
Armata Pharmaceuticals Inc
16% Upside
BAVA
Bavarian Nordic A/S
28% Upside
PEB
Pacific Edge Ltd
29% Downside
2171
CARsgen Therapeutics Holdings Ltd
40% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
9% Upside
ACAD
ACADIA Pharmaceuticals Inc
12% Upside
IONS
Ionis Pharmaceuticals Inc
6% Upside
ADAG
Adagene Inc
470% Upside

Revenue
Forecast

Revenue Estimate
Noile-Immune Biotech Inc

For the last 3 years the compound annual growth rate for Noile-Immune Biotech Inc's revenue is -58%. The projected CAGR for the next 3 years is 242%.

-58%
Past Growth
242%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Noile-Immune Biotech Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Noile-Immune Biotech Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Noile-Immune Biotech Inc's stock price target?
Not Available

Noile-Immune Biotech Inc doesn't have any price targets made by Wall Street professionals.

What is Noile-Immune Biotech Inc's Revenue forecast?
Projected CAGR
242%

For the last 3 years the compound annual growth rate for Noile-Immune Biotech Inc's revenue is -58%. The projected CAGR for the next 3 years is 242%.

Back to Top